NYSE:WEI - Weidai Stock Price, Forecast & News

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

Weidai is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Weidai.

2 brokerages have issued 1 year target prices for Weidai's stock. Their forecasts range from $5.40 to $5.40. On average, they anticipate Weidai's share price to reach $5.40 in the next year. This suggests a possible upside of 111.8% from the stock's current price. View Analyst Price Targets for Weidai.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 2 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Weidai.

Press coverage about WEI stock has been trending extremely negative on Sunday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Weidai earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Weidai.

Some companies that are related to Weidai include Oportun Financial (OPRT), Yirendai (YRD), America First Multifamily Investors (ATAX), Curo Group (CURO), CNFinance (CNF), On Deck Capital (ONDK), X Financial (XYF), Wins Finance (WINS), Jiayin Group (JFIN), Elevate Credit (ELVT), Medallion Financial (MFIN), Security National Financial (SNFCA), Consumer Portfolio Services (CPSS), Mogo Finance Technology (MOGO) and Fincera (YUANF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Energy Transfer LP Unit (ET), Methanex (MEOH), Netflix (NFLX), Voyager Therapeutics (VYGR), Walgreens Boots Alliance (WBA), International Paper (IP), AT&T (T), American Airlines Group (AAL) and Amphastar Pharmaceuticals (AMPH).

(WEI) raised $45 million in an initial public offering on Thursday, November 15th 2018. The company issued 4,500,000 shares at a price of $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WEI stock can currently be purchased for approximately $2.55.

Weidai has a market capitalization of $179.65 million and generates $569.19 million in revenue each year. The company earns $87.50 million in net income (profit) each year or $1.59 on an earnings per share basis. Weidai employs 9,919 workers across the globe.View Additional Information About Weidai.

The official website for Weidai is http://www.weidai.com.cn/.

Weidai's mailing address is 50F WEST BUILDING FORTUNE FINANCE CENTER NO.33 JIEFANG EAST ROAD JIANGGAN DISTRI, HANGZHOU F4, 310000. The company can be reached via phone at 86-185-0164-1666 or via email at [email protected]